1 August 2024 false Taxfiler 2024.6 09141640 business:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 09141640 2024-07-31 09141640 2024-08-01 2025-07-31 09141640 business:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 09141640 business:FilletedAccounts 2024-08-01 2025-07-31 09141640 2025-07-31 09141640 business:Director1 2024-08-01 2025-07-31 09141640 business:RegisteredOffice 2024-08-01 2025-07-31 09141640 2024-07-31 09141640 core:WithinOneYear 2025-07-31 09141640 core:WithinOneYear 2024-07-31 09141640 core:ShareCapital core:PreviouslyStatedAmount 2025-07-31 09141640 core:ShareCapital core:PreviouslyStatedAmount 2024-07-31 09141640 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-07-31 09141640 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-07-31 09141640 core:PreviouslyStatedAmount 2025-07-31 09141640 core:PreviouslyStatedAmount 2024-07-31 09141640 business:SmallEntities 2024-08-01 2025-07-31 09141640 countries:EnglandWales 2024-08-01 2025-07-31 09141640 core:ComputerEquipment 2024-08-01 2025-07-31 09141640 core:ComputerEquipment 2024-07-31 09141640 core:ComputerEquipment 2025-07-31 09141640 core:AcceleratedTaxDepreciationDeferredTax 2025-07-31 09141640 core:AcceleratedTaxDepreciationDeferredTax 2024-07-31 09141640 2023-07-31 09141640 2023-08-01 2024-07-31 09141640 business:OrdinaryShareClass1 2024-08-01 2025-07-31 09141640 business:OrdinaryShareClass1 2023-08-01 2024-07-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 09141640 (England and Wales)
Bond Biomedical Services Limited Unaudited accounts for the year ended 31 July 2025
Bond Biomedical Services Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Bond Biomedical Services Limited Company Information for the year ended 31 July 2025
Director
L Cameron
Company Number
09141640 (England and Wales)
Registered Office
Flat 6 Quartz House Dickens Yard 12 New Broadway London W5 2XA England
Accountants
Alport Management Services Limiited 5 Field End Maresfield Uckfield East Sussex TN22 2DJ
- 3 -
Bond Biomedical Services Limited Statement of financial position as at 31 July 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
1,134
1,882
Current assets
Debtors
5
6,422
8,152
Cash at bank and in hand
4,250
4,797
10,672
12,949
Creditors: amounts falling due within one year
6
(4,001)
(8,158)
Net current assets
6,671
4,791
Total assets less current liabilities
7,805
6,673
Provisions for liabilities
Deferred tax
7
(215)
(358)
Net assets
7,590
6,315
Capital and reserves
Called up share capital
8
1
1
Profit and loss account
7,589
6,314
Shareholders' funds
7,590
6,315
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 7 March 2026 and were signed on its behalf by
L Cameron Director Company Registration No. 09141640
- 4 -
Bond Biomedical Services Limited Notes to the Accounts for the year ended 31 July 2025
1
Statutory information
Bond Biomedical Services Limited is a private company, limited by shares, registered in England and Wales, registration number 09141640. The registered office is Flat 6 Quartz House, Dickens Yard, 12 New Broadway, London, W5 2XA, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover represents the value, net of VAT and discounts, for work carried out to clients.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% straight line basis
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Pension costs
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
- 5 -
Bond Biomedical Services Limited Notes to the Accounts for the year ended 31 July 2025
4
Tangible fixed assets
Computer equipment
£
Cost or valuation
At cost
At 1 August 2024
6,418
At 31 July 2025
6,418
Depreciation
At 1 August 2024
4,536
Charge for the year
748
At 31 July 2025
5,284
Net book value
At 31 July 2025
1,134
At 31 July 2024
1,882
5
Debtors
2025
2024
£
£
Amounts falling due within one year
Trade debtors
5,600
6,509
Accrued income and prepayments
822
1,643
6,422
8,152
6
Creditors: amounts falling due within one year
2025
2024
£
£
Taxes and social security
441
268
Loans from directors
3,560
7,890
4,001
8,158
7
Deferred taxation
2025
2024
£
£
Accelerated capital allowances
215
358
2025
2024
£
£
Provision at start of year
358
265
(Credited)/charged to the profit and loss account
(143)
93
Provision at end of year
215
358
8
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1
1
- 6 -
Bond Biomedical Services Limited Notes to the Accounts for the year ended 31 July 2025
9
Transactions with related parties
The Company was under the control of the Director. The director continued to provide the company with a loan and at the balance sheet date the balance was £3560 (2024:£7890). No other transactions required reporting during the year.
10
Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 7 -